KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
87 hedge funds and large institutions have $280M invested in Kindred Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+3
Holders Change %
+3.57%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
21
Reduced
22
Closed
31
Calls
$4.06M
Puts
$830K
Net Calls
+$3.23M
Net Calls Change
+$2.63M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$25.2M |
| 2 |
2
Fidelity International
Hamilton,
Bermuda
|
$16.6M |
| 3 |
PAMP
3
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
$6.62M |
| 4 |
GF
4
Gabelli Funds
Rye,
New York
|
$7.78M |
| 5 |
5
Morgan Stanley
New York
|
$6.48M |
